Zocdoc will let AI agents like Instinct and Google's Gemini book doctor appointments, ensuring verified doctors and insurance coverage.

For­ma­tion Bio, an AI-fo­cused biotech that ac­quires out­side as­sets, de­vel­ops them and then hands them off, has raised ...

FDA releases CRISPR medicine framework for personalized gene therapies, building on Baby KJ's case. Danaher's Kassim flags ...

AstraZeneca delays a third lung cancer readout to 2027 after a run of trial failures, raising pressure on next year’s data.

HHS on Wednes­day said it will stop en­forc­ing a ban on the com­pound­ing of cer­tain pop­u­lar pep­tides used for well­ness pur­pos­es while the FDA works on rule­mak­ing to ad­dress the sub­stances ...

Pfizer’s flood-damaged Gujarat cancer drug plant won’t resupply until 2028, deepening US chemotherapy shortages, ASHP said.

Scientists are the biggest converts in Endpoints Signal’s Q3 survey, with 78% of them now saying they expect AI to boost drug ...

Astellas takes an option on Audax’s preclinical IL-12 drug DAX-044 for $285M upfront and option fees, plus up to $1.05B in ...

Anthropic buys Mithril Medicine, a one-person stealth biotech backed by Atlas whose founder ran the “Professor Oak” account ...

Plowshare Therapies, led by Kevin Strauss, aims to develop a gene therapy for maple syrup urine disease, targeting ...

Gubra plans to expand beyond obesity into aging and I&I, targeting 8-10 clinical assets by 2030 and its first venture-built ...

Researchers had been testing whether Artiva's off-the-shelf NK cell therapy called AB-101 could treat rheumatoid arthritis and other autoimmune diseases.